Analyst Ratings For NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
Today, Needham & Company LLC reiterated its Buy ➝ Buy rating on NASDAQ:ARQL – ArQule (NASDAQ:ARQL) with a price target of $5.00 ➝ $6.00.
Some recent analyst ratings include
- 5/8/2018-Needham & Company LLC Reiterated Rating of Buy ➝ Buy.
- 4/5/2018-Leerink Swann Upgrade from a “Market Perform ➝ Outperform” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
NASDAQ:ARQL – ArQule (NASDAQ:ARQL) has insider ownership of 7.90% and institutional ownership of 67.15%.
- On 4/18/2018 Value Fund L P Biotechnology, Insider, sold 2,230,373 with an average share price of $3.10 per share and the total transaction amounting to $6,914,156.30.
- On 4/4/2018 Value Fund L P Biotechnology, Insider, sold 2,301,581 with an average share price of $2.90 per share and the total transaction amounting to $6,674,584.90.
- On 9/7/2017 Paolo Pucci, CEO, bought 1,101 with an average share price of $1.15 per share and the total transaction amounting to $1,266.15.
- On 9/6/2017 Paolo Pucci, CEO, bought 16,397 with an average share price of $1.15 per share and the total transaction amounting to $18,856.55.
- On 9/5/2017 Paolo Pucci, CEO, bought 19,156 with an average share price of $1.14 per share and the total transaction amounting to $21,837.84.
- On 8/29/2017 Paolo Pucci, CEO, bought 300 with an average share price of $1.05 per share and the total transaction amounting to $315.00.
- On 8/28/2017 Paolo Pucci, CEO, bought 2,970 with an average share price of $1.05 per share and the total transaction amounting to $3,118.50.
Recent Trading Activity for NASDAQ:ARQL – ArQule (NASDAQ:ARQL)
Shares of NASDAQ:ARQL – ArQule closed the previous trading session at 2.48 down -0.03 1.00% with 2.490000009536743 shares trading hands.